Enzymatic vitreolysis for the treatment of tractional diabetic macular edema

Enzymatic vitreolysis for the treatment of tractional diabetic macular edema

Background: A new approach to address focal vitreomacular adhesion in patients with diabetic macular edema may control and stabilize diabetic macular edema with fewer anti-vascular endothelial growth factor injections. Objectives: The aim of this study was to demonstrate that diabetic macular edema...

Full description

Bibliographic Details
Main Authors:	Bernardete Pessoa, João Coelho, Constança Coelho, Sílvia Monteiro, Carolina Abreu, João Figueira, Angelina Meireles, João Nuno Melo Beirão
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-08-01
Series:	Therapeutic Advances in Ophthalmology
Online Access:	https://doi.org/10.1177/2515841419869511

Similar Items

Vitrectomized versus non-vitrectomized eyes in diabetic macular edema response to ranibizumab—retinal layers thickness as prognostic biomarkers
by: Bernardete Pessoa, et al.
Published: (2021-11-01)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
by: Raczyńska D, et al.
Published: (2015-11-01)

Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
by: Hüseyin Baran Özdemir, et al.
Published: (2019-08-01)

Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction
by: Clement K Chan, et al.
Published: (2017-01-01)

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®)
by: João Coelho, et al.
Published: (2019-01-01)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
by: Pessoa B, et al.
Published: (2021-10-01)

Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction
by: Ahmed N. Fouad, et al.
Published: (2022-03-01)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
by: Coelho J, et al.
Published: (2019-09-01)

Pharmacologic Vitreolysis
by: Hossein Nazari, et al.
Published: (2010-01-01)

Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
by: Osama R Elnaggar, et al.
Published: (2023-01-01)

Pneumatic vitreolysis versus vitrectomy for the treatment of vitreomacular traction syndrome and macular holes: complication analysis and systematic review with meta-analysis of functional outcomes
by: Miguel A. Quiroz-Reyes, et al.
Published: (2023-05-01)

YAG laser vitreolysis for floaters
by: Tie-Zhu Lin, et al.
Published: (2023-03-01)

Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
by: David R.P. Almeida, et al.
Published: (2014-02-01)

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
by: Pessoa B, et al.
Published: (2020-09-01)

Closure of a full-thickness idiopathic macular hole in a young patient treated with pneumatic vitreolysis
by: David Paredes Saa, et al.
Published: (2020-01-01)

The morphometric peculiarities of the eyes with tractional macular edema after age-related cataract phacoemulsification
by: V.A. Rudenko, et al.
Published: (2013-03-01)

THE MORPHOMETRIC PECULIARITIES OF THE EYES WITH TRACTIONAL MACULAR EDEMA AFTER AGE-RELATED CATARACT PHACOEMULSIFICATION
by: V. A. Rudenko, et al.
Published: (2015-12-01)

Recurrent Diabetic Macular Edema: What to Do
by: Rita Santos Gonçalves, et al.
Published: (2017-09-01)

Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa
by: Mikiko Takezawa, et al.
Published: (2011-02-01)

Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
by: Francesco Pignatelli, et al.
Published: (2023-04-01)

A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole
by: Kevin H. Nguyen, et al.
Published: (2022-03-01)

Outcomes of cystoid macular edema following Descemet’s membrane endothelial keratoplasty in a referral center for keratoplasty in Spain: retrospective study
by: Nuno Moura-Coelho, et al.
Published: (2023-02-01)

Optimized technology of YAG-laser vitreolysis of occurrence of the vitreous body
by: Yu. Yu. Khzardzhan, et al.
Published: (2021-10-01)

The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment
by: Wan Ni Goh, et al.
Published: (2022-01-01)

Clinical observation of Ultra Q-YAG vitreolysis for vitreous floaters
by: Jing Li, et al.
Published: (2016-07-01)

23G vitrectomy outcomes of macular edema in retinal vein occlusion combined with vitreomacular traction or epiretinal membrane
by: Sheng-Xiang Guo, et al.
Published: (2017-09-01)

Three-year outcomes of vitrectomy combined with intraoperative dexamethasone implantation for non-tractional refractory diabetic macular edema
by: Sungsoon Hwang, et al.
Published: (2021-01-01)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01)

Evaluation of markers of outcome in real-world treatment of diabetic macular edema
by: António Campos, et al.
Published: (2018-10-01)

Aspectos atuais no diagnóstico do edema macular diabético Recent aspects on diagnosis of diabetic macular edema
by: Mário Martins dos Santos Motta, et al.
Published: (2009-02-01)

Comparative analysis of YAG laser vitreolysis and posterior vitrectomy in diabetic hemophthalmus
by: E. M. Gasimov, et al.
Published: (2014-10-01)

Quality of life results after vitreolysis in patients with symptomatic vitreous floaters
by: Renzo Canote, et al.
Published: (2020-01-01)

Mechanisms of macular edema
by: Cameron D. Haydinger, et al.
Published: (2023-03-01)

Aspectos atuais na fisiopatologia do edema macular diabético Recent aspects on physiopathology of diabetic macular edema
by: Mário Martins dos Santos Motta, et al.
Published: (2008-02-01)

LASER PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA: EFFECTS ON VISUAL ACUITY AND MACULAR EDEMA
by: M.H. Dehghan, et al.
Published: (1999-06-01)

LASER PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA: EFFECTS ON VISUAL ACUITY AND MACULAR EDEMA
by: M.H. Dehghan, et al.
Published: (1999-03-01)

Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
by: Figueira J, et al.
Published: (2021-07-01)

No side effects on rabbit retina or vitreous microenvironment by nd:YAG laser vitreolysis
by: Tiezhu Lin, et al.
Published: (2024-04-01)

Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia
by: Tie-Zhu Lin, et al.
Published: (2023-11-01)

Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters
by: Jihan Luo, et al.
Published: (2018-11-01)